Understanding TCP11: A Protein Potential Drug Target and Biomarker

Target Name: TCP11

NCBI ID: G6954

TCP11

Understanding TCP11: A Protein Potential Drug Target and Biomarker

TCP11, also known as T-complex 11, is a protein that is expressed in many different tissues throughout the body. It is a key regulator of the cytoskeleton, which is the structure that gives cells their shape and helps them move and function.

In recent years, researchers have been interested in studying TCP11 because of its potential as a drug target. Studies have shown that TCP11 can be modified by certain chemical treatments, which can affect its structure and function. This makes it a promising target for researchers who are looking for new ways to treat a variety of diseases.

One of the ways that TCP11 has been modified is through the addition of a genetic variation called the missense mutation. This mutation has been shown to alter the way that TCP11 functions in the cytoskeleton.

In addition to its potential as a drug target, TCP11 has also been studied for its potential as a biomarker. Researchers have shown that TCP11 levels can be used as a diagnostic marker for a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

One of the challenges in studying TCP11 is its complex structure. Because it is a protein that is expressed in many different tissues, it is difficult to study in isolation. Researchers have used a variety of techniques to study its behavior, including biochemical, cellular, and animal models.

In addition to its academic and industrial applications, TCP11 is also of interest to the pharmaceutical and biotechnology industries. Its unique structure and function make it a potential candidate for a variety of drugs and other biologic agents.

Overall, TCP11 is a protein that has the potential to be a drug target and a biomarker. Further research is needed to fully understand its behavior and its potential as a therapeutic agent.

Protein Name: T-complex 11

Functions: Plays a role in the process of sperm capacitation and acrosome reactions. Probable receptor for the putative fertilization-promoting peptide (FPP) at the sperm membrane that may modulate the activity of the adenylyl cyclase cAMP pathway

The "TCP11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TCP11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets